Osteoporosis in Wilson’s disease: A large cohort study highlighting age, sex and skeletal symptoms as key risk factors for clinical surveillance
Abstract Background Wilson’s disease (WD) is a rare disorder affecting copper metabolism that is characterized by multiple organ system damage, including the liver, brain, and eyes. Patients with WD are at risk for decreased bone mineral density (BMD). Only a few studies have investigated the relati...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Orphanet Journal of Rare Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13023-025-03910-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849235731019464704 |
|---|---|
| author | Ling Zhu Bin Song Yun Xu Yu-long Zhu Lei Hua Na Nian Long Zhang Quan Sun Ben-chun Xue Yin Xu Yong-sheng Han |
| author_facet | Ling Zhu Bin Song Yun Xu Yu-long Zhu Lei Hua Na Nian Long Zhang Quan Sun Ben-chun Xue Yin Xu Yong-sheng Han |
| author_sort | Ling Zhu |
| collection | DOAJ |
| description | Abstract Background Wilson’s disease (WD) is a rare disorder affecting copper metabolism that is characterized by multiple organ system damage, including the liver, brain, and eyes. Patients with WD are at risk for decreased bone mineral density (BMD). Only a few studies have investigated the relationship between WD and BMD, and there are discrepancies in the data. Therefore, we investigated the BMD status of patients with WD and analyzed the risk factors affecting the bone mass change. Methods This retrospective cohort study selected 426 patients with WD who were admitted to a neurological hospital in Hefei, China, from January 2018 to August 2024 as study subjects. The enrolled patients were divided into the osteoporosis group (13 patients), osteopenia group (99 patients), and normal bone mass group (314 patients). The rates of prevalence of osteoporosis and osteopenia were calculated, and the risk factors of osteoporosis and osteopenia were analyzed by multivariate ordered logistic regression. Results The prevalence of osteoporosis and osteopenia in patients with WD was 3.1% and 23.2%, respectively. Multivariate ordered logistic regression analysis demonstrated that age, male sex, and the presence of skeletal symptoms during the course of the disease were independent risk factors for osteoporosis and osteopenia in patients with WD, with odds ratio (OR) (95% confidence interval [CI]) values of 1.103 (1.074–1.134), 2.292 (1.216–4.320), and 2.675 (1.395–5.131), respectively. Conclusions Patients with WD with older age, male sex, and skeletal symptoms during the course of the disease are prone to osteoporosis and osteopenia changes. BMD monitoring and early intervention of such patients should be strengthened clinically. |
| format | Article |
| id | doaj-art-e09ddc645cdf434ca55efc8a0f4ad504 |
| institution | Kabale University |
| issn | 1750-1172 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | BMC |
| record_format | Article |
| series | Orphanet Journal of Rare Diseases |
| spelling | doaj-art-e09ddc645cdf434ca55efc8a0f4ad5042025-08-20T04:02:41ZengBMCOrphanet Journal of Rare Diseases1750-11722025-07-012011910.1186/s13023-025-03910-1Osteoporosis in Wilson’s disease: A large cohort study highlighting age, sex and skeletal symptoms as key risk factors for clinical surveillanceLing Zhu0Bin Song1Yun Xu2Yu-long Zhu3Lei Hua4Na Nian5Long Zhang6Quan Sun7Ben-chun Xue8Yin Xu9Yong-sheng Han10Institute of Neurology, Anhui University of Chinese MedicineInstitute of Neurology, Anhui University of Chinese MedicineInstitute of Neurology, Anhui University of Chinese MedicineAffiliated Hospital of Institute of Neurology, Anhui University of Chinese MedicineAffiliated Hospital of Institute of Neurology, Anhui University of Chinese MedicineAffiliated Hospital of Institute of Neurology, Anhui University of Chinese MedicineAffiliated Hospital of Institute of Neurology, Anhui University of Chinese MedicineAffiliated Hospital of Institute of Neurology, Anhui University of Chinese MedicineAffiliated Hospital of Institute of Neurology, Anhui University of Chinese MedicineInstitute of Neurology, Anhui University of Chinese MedicineInstitute of Neurology, Anhui University of Chinese MedicineAbstract Background Wilson’s disease (WD) is a rare disorder affecting copper metabolism that is characterized by multiple organ system damage, including the liver, brain, and eyes. Patients with WD are at risk for decreased bone mineral density (BMD). Only a few studies have investigated the relationship between WD and BMD, and there are discrepancies in the data. Therefore, we investigated the BMD status of patients with WD and analyzed the risk factors affecting the bone mass change. Methods This retrospective cohort study selected 426 patients with WD who were admitted to a neurological hospital in Hefei, China, from January 2018 to August 2024 as study subjects. The enrolled patients were divided into the osteoporosis group (13 patients), osteopenia group (99 patients), and normal bone mass group (314 patients). The rates of prevalence of osteoporosis and osteopenia were calculated, and the risk factors of osteoporosis and osteopenia were analyzed by multivariate ordered logistic regression. Results The prevalence of osteoporosis and osteopenia in patients with WD was 3.1% and 23.2%, respectively. Multivariate ordered logistic regression analysis demonstrated that age, male sex, and the presence of skeletal symptoms during the course of the disease were independent risk factors for osteoporosis and osteopenia in patients with WD, with odds ratio (OR) (95% confidence interval [CI]) values of 1.103 (1.074–1.134), 2.292 (1.216–4.320), and 2.675 (1.395–5.131), respectively. Conclusions Patients with WD with older age, male sex, and skeletal symptoms during the course of the disease are prone to osteoporosis and osteopenia changes. BMD monitoring and early intervention of such patients should be strengthened clinically.https://doi.org/10.1186/s13023-025-03910-1Wilson’s diseaseQuantitative CTBone mineral densityOsteoporosisOsteopenia |
| spellingShingle | Ling Zhu Bin Song Yun Xu Yu-long Zhu Lei Hua Na Nian Long Zhang Quan Sun Ben-chun Xue Yin Xu Yong-sheng Han Osteoporosis in Wilson’s disease: A large cohort study highlighting age, sex and skeletal symptoms as key risk factors for clinical surveillance Orphanet Journal of Rare Diseases Wilson’s disease Quantitative CT Bone mineral density Osteoporosis Osteopenia |
| title | Osteoporosis in Wilson’s disease: A large cohort study highlighting age, sex and skeletal symptoms as key risk factors for clinical surveillance |
| title_full | Osteoporosis in Wilson’s disease: A large cohort study highlighting age, sex and skeletal symptoms as key risk factors for clinical surveillance |
| title_fullStr | Osteoporosis in Wilson’s disease: A large cohort study highlighting age, sex and skeletal symptoms as key risk factors for clinical surveillance |
| title_full_unstemmed | Osteoporosis in Wilson’s disease: A large cohort study highlighting age, sex and skeletal symptoms as key risk factors for clinical surveillance |
| title_short | Osteoporosis in Wilson’s disease: A large cohort study highlighting age, sex and skeletal symptoms as key risk factors for clinical surveillance |
| title_sort | osteoporosis in wilson s disease a large cohort study highlighting age sex and skeletal symptoms as key risk factors for clinical surveillance |
| topic | Wilson’s disease Quantitative CT Bone mineral density Osteoporosis Osteopenia |
| url | https://doi.org/10.1186/s13023-025-03910-1 |
| work_keys_str_mv | AT lingzhu osteoporosisinwilsonsdiseasealargecohortstudyhighlightingagesexandskeletalsymptomsaskeyriskfactorsforclinicalsurveillance AT binsong osteoporosisinwilsonsdiseasealargecohortstudyhighlightingagesexandskeletalsymptomsaskeyriskfactorsforclinicalsurveillance AT yunxu osteoporosisinwilsonsdiseasealargecohortstudyhighlightingagesexandskeletalsymptomsaskeyriskfactorsforclinicalsurveillance AT yulongzhu osteoporosisinwilsonsdiseasealargecohortstudyhighlightingagesexandskeletalsymptomsaskeyriskfactorsforclinicalsurveillance AT leihua osteoporosisinwilsonsdiseasealargecohortstudyhighlightingagesexandskeletalsymptomsaskeyriskfactorsforclinicalsurveillance AT nanian osteoporosisinwilsonsdiseasealargecohortstudyhighlightingagesexandskeletalsymptomsaskeyriskfactorsforclinicalsurveillance AT longzhang osteoporosisinwilsonsdiseasealargecohortstudyhighlightingagesexandskeletalsymptomsaskeyriskfactorsforclinicalsurveillance AT quansun osteoporosisinwilsonsdiseasealargecohortstudyhighlightingagesexandskeletalsymptomsaskeyriskfactorsforclinicalsurveillance AT benchunxue osteoporosisinwilsonsdiseasealargecohortstudyhighlightingagesexandskeletalsymptomsaskeyriskfactorsforclinicalsurveillance AT yinxu osteoporosisinwilsonsdiseasealargecohortstudyhighlightingagesexandskeletalsymptomsaskeyriskfactorsforclinicalsurveillance AT yongshenghan osteoporosisinwilsonsdiseasealargecohortstudyhighlightingagesexandskeletalsymptomsaskeyriskfactorsforclinicalsurveillance |